BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19648108)

  • 21. Clarithromycin attenuates autophagy in myeloma cells.
    Nakamura M; Kikukawa Y; Takeya M; Mitsuya H; Hata H
    Int J Oncol; 2010 Oct; 37(4):815-20. PubMed ID: 20811702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 8-amino-adenosine is a potential therapeutic agent for multiple myeloma.
    Krett NL; Davies KM; Ayres M; Ma C; Nabhan C; Gandhi V; Rosen ST
    Mol Cancer Ther; 2004 Nov; 3(11):1411-20. PubMed ID: 15542780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor Activity of Asiaticoside Against Multiple Myeloma Drug-Resistant Cancer Cells Is Mediated by Autophagy Induction, Activation of Effector Caspases, and Inhibition of Cell Migration, Invasion, and STAT-3 Signaling Pathway.
    Yingchun L; Huihan W; Rong Z; Guojun Z; Ying Y; Zhuogang L
    Med Sci Monit; 2019 Feb; 25():1355-1361. PubMed ID: 30785126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. R-(-)-gossypol (AT-101) activates programmed cell death in multiple myeloma cells.
    Kline MP; Rajkumar SV; Timm MM; Kimlinger TK; Haug JL; Lust JA; Greipp PR; Kumar S
    Exp Hematol; 2008 May; 36(5):568-76. PubMed ID: 18346839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway.
    De Veirman K; Menu E; Maes K; De Beule N; De Smedt E; Maes A; Vlummens P; Fostier K; Kassambara A; Moreaux J; Van Ginderachter JA; De Bruyne E; Vanderkerken K; Van Valckenborgh E
    Cancer Lett; 2019 Feb; 442():233-241. PubMed ID: 30419344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ClC5 Decreases the Sensitivity of Multiple Myeloma Cells to Bortezomib via Promoting Prosurvival Autophagy.
    Zhang H; Pang Y; Ma C; Li J; Wang H; Shao Z
    Oncol Res; 2018 Apr; 26(3):421-429. PubMed ID: 28899456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
    Wang Y; Xu W; Yan Z; Zhao W; Mi J; Li J; Yan H
    J Exp Clin Cancer Res; 2018 Mar; 37(1):63. PubMed ID: 29554968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of glucose transporter 1 induces apoptosis and sensitizes multiple myeloma cells to conventional chemotherapeutic agents.
    Matsumoto T; Jimi S; Migita K; Takamatsu Y; Hara S
    Leuk Res; 2016 Feb; 41():103-10. PubMed ID: 26790725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cold PSM, but not TRAIL, triggers autophagic cell death: A therapeutic advantage of PSM over TRAIL.
    Ito T; Ando T; Suzuki-Karasaki M; Tokunaga T; Yoshida Y; Ochiai T; Tokuhashi Y; Suzuki-Karasaki Y
    Int J Oncol; 2018 Aug; 53(2):503-514. PubMed ID: 29845256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Proteasome Inhibitor Bortezomib Maintains Osteocyte Viability in Multiple Myeloma Patients by Reducing Both Apoptosis and Autophagy: A New Function for Proteasome Inhibitors.
    Toscani D; Palumbo C; Dalla Palma B; Ferretti M; Bolzoni M; Marchica V; Sena P; Martella E; Mancini C; Ferri V; Costa F; Accardi F; Craviotto L; Aversa F; Giuliani N
    J Bone Miner Res; 2016 Apr; 31(4):815-27. PubMed ID: 26551485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resveratrol induces AMPK and mTOR signaling inhibition-mediated autophagy and apoptosis in multiple myeloma cells.
    Ma R; Yu D; Peng Y; Yi H; Wang Y; Cheng T; Shi B; Yang G; Lai W; Wu X; Lu Y; Shi J
    Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):775-783. PubMed ID: 33891090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Autophagy is involved in doxorubicin induced resistance of human myeloma cell line RPMI8226].
    Pan YZ; Wang X; Bai H; Wang CB; Zhang Q; Xi R
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):489-92. PubMed ID: 23827103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. S-Adenosylmethionine-mediated apoptosis is potentiated by autophagy inhibition induced by chloroquine in human breast cancer cells.
    Cave DD; Desiderio V; Mosca L; Ilisso CP; Mele L; Caraglia M; Cacciapuoti G; Porcelli M
    J Cell Physiol; 2018 Feb; 233(2):1370-1383. PubMed ID: 28518408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Silico Modeling-based Identification of Glucose Transporter 4 (GLUT4)-selective Inhibitors for Cancer Therapy.
    Mishra RK; Wei C; Hresko RC; Bajpai R; Heitmeier M; Matulis SM; Nooka AK; Rosen ST; Hruz PW; Schiltz GE; Shanmugam M
    J Biol Chem; 2015 Jun; 290(23):14441-53. PubMed ID: 25847249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracellular NAD(+) depletion induces autophagic death in multiple myeloma cells.
    Cea M; Cagnetta A; Patrone F; Nencioni A; Gobbi M; Anderson KC
    Autophagy; 2013 Mar; 9(3):410-2. PubMed ID: 23221771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 8-chloro-cAMP and 8-chloro-adenosine act by the same mechanism in multiple myeloma cells.
    Gandhi V; Ayres M; Halgren RG; Krett NL; Newman RA; Rosen ST
    Cancer Res; 2001 Jul; 61(14):5474-9. PubMed ID: 11454694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The novel autophagy inhibitor elaiophylin exerts antitumor activity against multiple myeloma with mutant TP53 in part through endoplasmic reticulum stress-induced apoptosis.
    Wang G; Zhou P; Chen X; Zhao L; Tan J; Yang Y; Fang Y; Zhou J
    Cancer Biol Ther; 2017 Aug; 18(8):584-595. PubMed ID: 28718729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 6-Azauridine Induces Autophagy-Mediated Cell Death via a p53- and AMPK-Dependent Pathway.
    Cha YE; Park R; Jang M; Park YI; Yamamoto A; Oh WK; Lee EJ; Park J
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of autophagy enhances the antitumour activity of tigecycline in multiple myeloma.
    Ma R; Zhang Y; Wang W; Wu J; Yang Q; Xu W; Jiang S; Han Y; Yu K; Zhang S
    J Cell Mol Med; 2018 Dec; 22(12):5955-5963. PubMed ID: 30247801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autophagy inhibitors chloroquine and LY294002 enhance temozolomide cytotoxicity on cutaneous melanoma cell lines in vitro.
    Ryabaya OO; Inshakov AN; Egorova AV; Emelyanova MA; Nasedkina TV; Zasedatelev AS; Khochenkov DA; Stepanova EV
    Anticancer Drugs; 2017 Mar; 28(3):307-315. PubMed ID: 27941537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.